PabloRodrigues Costa Alves Brazil

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	Hands on Big Data Mining for the Nephrologist in 2024 HeatherAscani Chairperson University of MichiganUnited States KatherineTuttle Chairperson University of Washington School of Medicine, Division of NephrologyUnited States MatthiasKretzler Chairperson University of MichiganUnited States Looking for Data on Glomerular Diseases: How to Find the Treasures You Are Looking for With a Click of a Mouse VijiNair Speaker University of MichiganUnited States Open Science in an Open Community: Resources of the Kidney Precision Medicine Project for CKD and AKI MatthiasKretzler Speaker University of MichiganUnited States The Future is Now: How to Mine Cells and Neighborhoods of the Kidney in Health and Disease JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deHeidelberg UniversityGermany Panel Discussion Hall C1
10:30 a.m. 11 a.m.	Hitting the Four Hits: The Potential of Dual BAFF/APRIL Inhibition in IgA Nephropathy JonathanBarratt Spotlight Speaker University of Leicester, Leicester, UKUnited Kingdom Spotlight Stage 1 (exhibition hall)
12:15 p.m. 1:15 p.m.	Hot Debate: Should a Low Protein Diet (+/- Ketoanalogue Supplementation) Be Part of Advanced CKD Management? CarlaAvesani Chairperson carla.avesani@ki.seKarolinska InstituteSweden SahirKalim Chairperson skalim@mgh.harvard.eduHarvard Medical School/ Massachusetts General Hospital United States Hot Debate: Should Low Protein Diet (+/- Ketoanalogue Supplementation) Be a Part of Advanced CKD Management? - PROS ConnieRhee Speaker crhee@mednet.ucla.eduUCLAUnited States Hot Debate: Should Low Protein Diet (+/- Ketoanalogue Supplementation) Be a Part of Advanced CKD Management? - CONS SwapnilHiremath Speaker University of OttawaCanada Hall A	Onconephrology: Various Flavors of AKI JavierDe Arteaga Chairperson javierdearteaga@gmail.comHospital Privado Universitario de Cordoba. Catholic University from CordobaArgentina KarinaSoto Chairperson Centro Hospitalar de Setubal, EPE and CEDOC Universidade Nova de LisboaPortugal SandraHerrmann Chairperson herrmann.sandra@mayo.eduMayo ClinicUnited States AKI-related Cancer and Cancer Treatment-related TMA ClaraGarcía Carro Speaker claragarciacarro@hotmail.comSan Carlos Clinical Hospital (Madrid, Spain)Spain AKI Related to Cancer Immunotherapy: Can Biomarkers Help? SebastianLapman Speaker lapseba@yahoo.com.arArgentina Magnesium and AKI: Is There a Connection? From Bench to Bedside - What We Can Learn from Onconephrology JolantaMalyszko Speaker Medical University of Warsaw, PolandPoland Q and A Hall E
1 p.m. 1:45 p.m.	Kidney Tank: Social Media as a Professional Tool MythriShankar Spotlight Speaker Institute of NephrourologyIndia Augusto CesarSoares dos Santos Junior Spotlight Chairperson Hospital das Clinicas, UFMG; Fac Ciências MedicasBrazil FernandaArce Spotlight Chairperson Mexico RolandoClaure Del Granado Spotlight Speaker Division of Nephrology, Hospital Obrero No 2 - Caja Nacional de Salud, Cochabamba Bolivia Spotlight Stage 2
2:45 p.m. 3:30 p.m.	What is ongoing in CKDu around the world? - CKDU interactive discussions (ISN i3C) ErangaWijewickrama Spotlight Chairperson Faculty of Medicine, University of ColomboSri Lanka Jose VicenteSanchez Polo Spotlight Chairperson visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala Magdalena Madero Spotlight Speaker Chief of Nephrology, Instituto Nacional de CardiolMexico VivekanandJha Spotlight Speaker George Institute for Global Health IndiaIndia NishanthaNanyakkara Spotlight Speaker nishantha4313@gmail.comSri Lanka Spotlight Stage 1 (exhibition hall)
3 p.m. 4 p.m.	A Balancing Act: Your Kidneys and Electrolytes Angela Yee-MoonWang Chairperson Hong Kong/SingaporeSingapore ThiagoDe Azevedo Reis Chairperson thiagoreisnefro@gmail.comHospital Sírio-Libanês, São Paulo, Brazil & Fenix Brazil Is Magnesium a Missing Puzzle for Vascular Calcification in CKD? SolaAoun Bahous Speaker sola.bahous@gmail.comLebanese American University School of MedicineLebanon Should Potassium Be Restricted or Not in CKD? RobertoPecoits Filho Speaker Arbor Research Collaborative for HealthUnited States Metabolic Acidosis in CKD: When to Treat? What to Target? MitchellRosner Speaker Univeristy of Virginia HealthUnited States Q and A Hall A
4 p.m. 4:30 p.m.	Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis BradRovin Spotlight Speaker The Ohio State UniversityUnited States UptalPatel Spotlight Speaker United States Spotlight Stage 1 (exhibition hall)
4:30 p.m. 5:30 p.m.	Building Competency in Nephrology Education Augusto CesarSoares dos Santos Junior Chairperson Hospital das Clinicas, UFMG; Fac Ciências MedicasBrazil Li-LiHsiao Chairperson lhsiao@bwh.harvard.eduBrigham and Women\'s Hospital, Harvard Medical SchoolUnited States Curriculum Design to Developing Competency in Nephrology Practice ReneScalet Dos Santos Neto Speaker renesantosneto@gmail.comFaculdades Pequeno Principe (FPP) - BrazilBrazil Developing Clinical Reasoning KarenWarburton Speaker KMW2G@uvahealth.orgUniversity of Virginia Health SystemUnited States Assessment of Nephrology Trainees to Ensure Competence SolaAoun Bahous Speaker sola.bahous@gmail.comLebanese American University School of MedicineLebanon Q and A Hall C2	New Developments in CKD Epidemiology Research MaartenTaal Chairperson University of NottinghamUnited Kingdom RobertoPecoits Filho Chairperson Arbor Research Collaborative for HealthUnited States Big Data Lab Patient-reported Outcome Measures: How Do Patients Experience CKD? AdeeraLevin Speaker University of British Columbia and Providence Health CareCanada Trial Simulation Using Observational Data AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgArbor Research Collaborative for HealthUnited States Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges DorotheaNitsch Speaker London School of Hygiene & Tropical MedicineUnited Kingdom Q and A Hall C4

Day 2 - Monday April 15, 2024

Time	Session

9 a.m. 10:30 a.m.	ADPKD Updates CarlosDiaz Chairperson cdiaz@cemic.edu.arSección Nefrología, Departamento de Medicina Interna, Instituto Universitario CEMIC.Argentina CristianKramer Chairperson cristiankramer@yahoo.eshosptial ramos mejìaArgentina Role of Genetic Testing in ADPKD PeterHarris Speaker harris.peter@mayo.eduMayo ClinicUnited States New Metabolic Pathways Driving PKD Progression AlessandraBoletta Speaker boletta.alessandra@hsr.itSan Raffaele Scientific InstituteItaly ADPKD Management Guidelines AlfredoWassermann Speaker awasser@gmail.comFEPREVAArgentina The Future Landscape for ADPKD Treatment VicenteTorres Speaker Mayo ClinicUnited States Q and A Hall C1						Insights From Understanding Heterogeneous Trajectories to Kidney Failure FacundoDaminato Chairperson fmdaminato@hotmail.comArgentina Magdalena Madero Chairperson Chief of Nephrology, Instituto Nacional de CardiolMexico PietroRavani Chairperson pravani@ucalgary.caUniversity of CalgaryCanada Non-neoplastic Lesions in Nephrectomy Samples: Implications for Kidney Function JairMunoz Mendoza Speaker JMMendoza@med.miami.eduUniversity of MiamiUnited States Understanding the Heterogeneous Trajectory of CKD MorganGrams Speaker morgan.grams@nyulangone.orgNew York UniversityUnited States Review of Medical Therapies Proven to Delay CKD Progression DoreenZhu Speaker doreen.zhu@ndph.ox.ac.ukUniversity of OxfordUnited Kingdom Impact of Obesity and Novel Treatment Strategies on CKD Progression PeterRossing Speaker Steno Diabetes Center Copenhagen Denmark Q and A Hall C4
10:30 a.m. 11 a.m.	Nephrology in Jeopardy: A Sustainable Kidney Care Quiz BrendanSmyth Spotlight Chairperson brendan.smyth@sydney.edu.auAustralia LetiziaDe Chiara Spotlight Chairperson letizia.dechiara@unifi.itDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence Italy UgochiOnu Spotlight Chairperson Nigeria Spotlight Stage 1 (exhibition hall)
11 a.m. 12 p.m.	Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel) Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala MegJardine Chairperson NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia Generative AI Revolution in Medicine MichalRosen-Zvi Speaker ROSEN@il.ibm.comhttps://research.ibm.com/Israel Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh) Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh Hall A
12:15 p.m. 1:15 p.m.	The Journey of a Patient with Kidney and Cardiovascular Diseases: From Detection to Referral to Co-management RobertoPecoits Filho Chairperson Arbor Research Collaborative for HealthUnited States Challenges in the Early Detection and Management of a Patient at the Interface of Kidney and Heart Disease MarisolTorres Toledano Speaker torres.t.marisol@gmail.comIMSS, MEXICO Mexico Co-management of Patients With Cardio-Kidney Diseases: Let DebasishBanerjee Speaker St George's University Hospital NHS Foundation TrUnited Kingdom Co-management of Patients With Cardio-Kidney Diseases: Let CharlesHerzog Speaker Charles.Herzog@cdrg.orgISN and Hennepin Healthcare/University of MinnesUnited States Q and A Hall C1						KDIGO 2024 Anemia Guideline: Case-based Illustrations: ISN-KDIGO Joint Session Carlos LuisBlanco Chairperson clbblanco@yahoo.com.arCARLOS LUIS BLANCO, ISN EMERIT MEMBER, ARGENTINA Argentina MarcelloTonelli Chairperson University of CalgaryCanada TalerngsakKanjanabuch Chairperson Faculty of Medicine, Chulalongkorn UniversityThailand KDIGO 2024 Anemia CKD Guideline: Overview on Methodology and Key Guidance EviNagler Speaker Nephrology Department, Ghent University Hospital, Belgium Practical Guideline Applications for Patients with Anemia CKD Not on Dialysis JoséA. Moura-Neto Speaker jamouraneto@hotmail.comBrazilian Society of NephrologyBrazil Practical Guideline Applications for Select Patients With Anemia: Dialysis, Kidney Transplant Recipients, and Children with CKD MarcelloTonelli Speaker University of CalgaryCanada Q and A Hall E
12:45 p.m. 1:30 p.m.	Keys to success to be on top of what is published in nephrology (ISN-ACT) AndreaViecelli Spotlight Speaker University of QueenslandAustralia Augusto CesarSoares dos Santos Junior Spotlight Speaker Hospital das Clinicas, UFMG; Fac Ciências MedicasBrazil BrendanSmyth Spotlight Speaker brendan.smyth@sydney.edu.auAustralia DavidWheeler Spotlight Speaker University College LondonUnited Kingdom MegJardine Spotlight Chairperson NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia Spotlight Stage 1 (exhibition hall)
3 p.m. 4 p.m.	Late Breaking Clinical Trials Session AlessiaFornoni Chairperson University of Miami United States MichelleRheault Chairperson rheau002@umn.eduUniversity of MinnesotaUnited States Predicting the Risks of Kidney Failure and Death in Adults With Moderate-to-severe Chronic Kidney Disease (KDpredict) PietroRavani Free Communication pravani@ucalgary.caUniversity of CalgaryCanada Plasma Exchange in ANCA Associated Vasculitis GN: Update After Pexivas Wladimir MietekSzpirt Speaker wladimir.mietek.szpirt.01@regionh.dkRigshospitalet, University of Copenhagen, Dept. of Nephrology, Denmark, Senior Research ConsultantDenmark EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY DanaRizk Free Communication drizk@uabmc.eduUniversity of Alabama at BirminghamUnited States SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL JonathanBarratt Free Communication University of Leicester, Leicester, UKUnited Kingdom PREGNANCY AMONG WOMEN ON CHRONIC DIALYSIS : THE FRENCH COHORT CécileCouchoud Free Communication cecile.couchoud@biomedecine.frREIN registry, Agence de la biomédecine, FranceFrance Hall A			Disparities in the Care of People Living with Kidney Failure in Latin America AdeeraLevin Chairperson University of British Columbia and Providence Health CareCanada AminuBello Chairperson University of AlbertaCanada Global Assessment of Kidney Care Capacity and Policy and Perspectives on Enhancing Global Kidney Care-Findings From the ISN-GKHA AminuBello Speaker University of AlbertaCanada State of CKD Care for Kidney Disease in Latin American Region Magdalena Madero Speaker Chief of Nephrology, Instituto Nacional de CardiolMexico Variability in The Burden, Management and Outcomes of Kidney Failure Between Children and Adults in Latin America MarinaWainstein Speaker Academia Nacional de Medicina de Buenos AiresArgentina Q and A Hall C1			Treatment Goals for Severe Hyponatremia: A Debate on Current Guidelines Program MitchellRosner Chairperson Univeristy of Virginia HealthUnited States Overview of Hyponatremia Angela Yee-MoonWang Speaker Hong Kong/SingaporeSingapore Pro: Current Guidelines are Appropriate HelbertRondon-Berrios Speaker rondonberriosh@upmc.eduUniversity of Pittsburgh School of MedicineUnited States Con: Current Guidelines are Too Conservative CarlosAyus Speaker carlosayus@yahoo.comUniversity of California IrvineUnited States Discussion Hall C3			Stewardship and Forward Planning in Stage Four CKD. ISN-KSN Joint Session AnaCusumano Chairperson anacusumano@gmail.com.arCEMIC University Institute School of Health SciencesArgentina Ana Elizabeth pradofigueiredo Chairperson Pontifícia Universidade Católica do Rio Grande do Brazil Sung GyunKim Chairperson imnksk@gmail.comHallym University Sacred Heart HospitalKorea (Republic of) Innovations in Managing Advanced CKD Through Telemedicine VivekanandJha Speaker George Institute for Global Health IndiaIndia New Approaches to CKD Patient Education to Promote Uptake of PD and Home Hemodialysis Annie-ClaireNadeau-Fredette Speaker annieclairenaf@gmail.comUniversité de MontréalCanada A Shared Decision Process to Uptake of Conservative Management of Kidney Failure in the Elderly SunitaBavanandan Speaker Hospital Kuala Lumpur, MalaysiaMalaysia Q and A Hall D
4:30 p.m. 5:30 p.m.	Recent Trends in Global Nephrology - Care of Advanced CKD and Dialysis Patients: ISN-DOPPS Joint Session Guang-YanCai Chairperson China JonathanChavez Iniguez Chairperson jonarchi_10@hotmail.comHospital Civil de Guadalajara, Universidad de GuadalajaraMexico CKD Care in Low-resource Settings: Lessons Learned from CKDOPPS Magdalena Madero Speaker Chief of Nephrology, Instituto Nacional de CardiolMexico PD Infections: Think Globally, Act Locally JeffreyPerl Speaker St. Michael's Hospital Canada International Trends and Variations in Hemodiafiltration Utilization and Practices AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgArbor Research Collaborative for HealthUnited States Q and A Hall C3				Personalized Kidney Replacement Treatment: Adapting Guidelines to Real-world Scenarios Annie-ClaireNadeau-Fredette Chairperson annieclairenaf@gmail.comUniversité de MontréalCanada Gabriel NicolasContreras Martin Chairperson gcontrer@med.miami.eduUniversity of Miami Miller School of MedicineUnited States Maria ElenaBiain Chairperson mariaelenabiain@yahoo.com.arMédica Nefróloga The Who, What, Where, When and Why of Incremental Hemodialysis ConnieRhee Speaker crhee@mednet.ucla.eduUCLAUnited States The Changing Landscape of Home Hemodialysis: Is There a Right Patient for Home Hemodialysis? KarthikTennankore Speaker ktennankore@gmail.comNova Scotia Health/Dalhousie UniversityCanada Patient-, Center- and Country-related Risk Factors for Peritoneal Dialysis Attrition: Can We Prevent It? RosileneM Elias Speaker rosilenemotta@hotmail.comUniversidade de Sao PauloBrazil Q and A Hall C4				Designing Smart Clinical Trials DebbieGipson Chairperson debbie.gipson@nih.govNational Institutes of Health/NIDDKUnited States JonathanBarratt Chairperson University of Leicester, Leicester, UKUnited Kingdom Patients Subphenotyping: The Example of Diabetic Kidney Disease John CijiangHe Speaker cijiang.he@mssm.eduIcahn School of Medicine at Mount SinaiUnited States Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease LauraMariani Speaker lmariani@umich.eduUniversity of MichiganUnited States Targeted Approaches in Clinical Trial Design HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Q and A Hall D
4:45 p.m. 5:30 p.m.	Implementing early CKD detection programs AdeeraLevin Spotlight Speaker University of British Columbia and Providence Health CareCanada Jose VicenteSanchez Polo Spotlight Speaker visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala LauraSola Spotlight Speaker Dialysis Center, CASMU-IAMPP Uruguay VivekanandJha Spotlight Speaker George Institute for Global Health IndiaIndia Spotlight Stage 1 (exhibition hall)

Day 3 - Tuesday April 16, 2024

Time	Session

9 a.m. 10 a.m.	Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment DebasishBanerjee Chairperson St George's University Hospital NHS Foundation TrUnited Kingdom MegJardine Chairperson NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia Setting the Scene MegJardine Speaker NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia DM and CKD: Which Treatment Should I Use for Different Populations? KatherineTuttle Speaker University of Washington School of Medicine, Division of NephrologyUnited States How to Design Studies on Answering Unanswered Questions VladoPerkovic Speaker University of New South Wales, Sydney, AustraliaAustralia The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes DavidWheeler Speaker University College LondonUnited Kingdom Q and A Hall C4
9 a.m. 10:30 a.m.	Clinical Management of Glomerulonephritis (GN) Juan ManuelMejia Vilet Chairperson jmmejia@hotmail.comInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico ValeriaAlberton Chairperson vgalberton@gmail.comHospital Fernandez/ Hospital El CruceArgentina Updates on IgAN Management HernánTrimarchi Speaker HOSPITAL BRITÁNICO DE BUENOS AIRESArgentina Membranous GN Classification and Management PierreRonco Speaker Hôpital TenonFrance MPGN Updates SanjeevSethi Speaker Mayo ClinicUnited States Managing Vasculitis RobertaFenoglio Speaker roberta.fenoglio@unito.itOspedale San Giovanni BoscoItaly Q and A Hall A
11 a.m. 12:15 p.m.	Plenary Session 4: Insights into SGLT2 Inhibitors: A Story of Discovery (Ele Ferrannini, Italy) AlessiaFornoni Chairperson University of Miami United States LizLightstone Chairperson Imperial College LondonUnited Kingdom MasaomiNangaku Chairperson Japan Acceptance Speech: Bywaters Award MotokoYanagita Speaker Kyoto UniversityJapan Insights into SGLT2 Inhibitors: A Story of Discovery. Donald Seldin Lecture EleFerrannini Speaker eleferrannini@gmail.comUniversity of PisaItaly ELP2 Graduation MasaomiNangaku Speaker Japan Hall A
12:30 p.m. 1:30 p.m.	Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? MarceloOrías Chairperson marcelo.orias@gmail.comArgentina MarkSarnak Chairperson msarnak@tuftsmedicalcenter.orgTufts Medical CenterUnited States Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - PROS TaraChang Speaker tichang@stanford.eduStanford UniversityUnited States Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - CONS JordanaCohen Speaker jco@pennmedicine.upenn.eduUniversity of PennsylvaniaUnited States Hall A	Complications and Nutritional Approaches to CKD: ISN-ISRNM Joint Session Angela Yee-MoonWang Chairperson Hong Kong/SingaporeSingapore ArmandoNegri Chairperson armando.negri@gmail.comInstituto de Investigaciones Metabólicas, Universidad del Salvador, Buenos Aires, ArgentinaArgentina CKD-induced Changes in Gut Microbiome in CKD DeniseMafra Speaker dmafra30@gmail.comFederal University Fluminense - UFFBrazil Personalized Nutrition Management of CKD Patients ConnieRhee Speaker crhee@mednet.ucla.eduUCLAUnited States The Gut-Kidney-Heart Axis in CKD: Beyond the Leaky Gut KeiichiSumida Speaker ksumida@uthsc.eduUniversity of Tennessee Health Science CenterUnited States Q and A Hall C4

Pre-Congress - Saturday April 13, 2024

Time	Session

9 a.m. 11 a.m.	Conservative Kidney Management Course: Fundamentals of Conservative Kidney Management CarlosZuniga Chairperson czunigasm2002@yahoo.comDirector of SLANH Kidney Palliative Care CommitteeChile FrankBrennan Chairperson St George HospitalAustralia SaraDavison Chairperson University of AlbertaCanada Introduction to the ISN CKM Curriculum and Objectives of the Day SaraDavison Speaker University of AlbertaCanada Introduction to Concepts/Principles of Kidney Supportive Care (KSC) and Conservative Kidney Management (CKM) SaraDavison Speaker University of AlbertaCanada Delivery of CKM SaraDavison Speaker University of AlbertaCanada Q and A Shared Decision-making around CKM SaharKoubar Speaker University of MinnesotaUnited States Q and A Practical Challenges for Implementing CKM: A Case Presentation and Round Table Discussion NicolaWearne Speaker Groote Schuur Hospital / university of Cape TownSouth Africa Hall C2
11:30 a.m. 1:30 p.m.	Conservative Kidney Management Course: Symptom Management CarlosZuniga Chairperson czunigasm2002@yahoo.comDirector of SLANH Kidney Palliative Care CommitteeChile FrankBrennan Chairperson St George HospitalAustralia SaraDavison Chairperson University of AlbertaCanada Introduction to the Session Including The Prevalence of Symptoms and Available Assessment Tools FrankBrennan Speaker St George HospitalAustralia Management of Uremic Pruritus and Restless Legs Syndrome in CKM FrankBrennan Speaker St George HospitalAustralia Q and A Pharmacologic Management of Pain in CKM SaraDavison Speaker University of AlbertaCanada Non-pharmacologic Management of Pain in CKM PramoteEuasobhon Speaker pramoteo@hotmail.comDepartment of Anesthesiology, Faculty of Medicine Thailand Q and A Management of Fatigue, Insomnia, Depression, and Anxiety in CKM GregorioObrador Vera Speaker gobrador@up.edu.mxUniversidad Panamericana School of MedicineMexico Q and A Hall C2
1 p.m. 2:30 p.m.	Sharing Expertise to Support the Set-up of Renal Registries: The Global Situation and Inspiration from Established Registries in Latin America: Part 1 FergusCaskey Chairperson University of Bristol, UKUnited Kingdom MariaPippias Chairperson University of BristolUnited Kingdom Welcome MasaomiNangaku Speaker Japan Introduction of SharE-RR FergusCaskey Speaker University of Bristol, UKUnited Kingdom Introduction of SharE-RR Toolkit MariaPippias Speaker University of BristolUnited Kingdom Current State of Registries Worldwide, 2023 ISN-GKHA AminuBello Speaker University of AlbertaCanada The History of Renal Registries In Latin America: 1950 - Current (Including PAHO Collaboration) MariaGonzalez Speaker registro@slanh.netSLANHUruguay The Argentinian Renal Registry GuillermoRosa Diez Speaker guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina Sala 1
2:15 p.m. 4:15 p.m.	Conservative Kidney Management Course: Capacity Building for CKM and Terminal Care CarlosZuniga Chairperson czunigasm2002@yahoo.comDirector of SLANH Kidney Palliative Care CommitteeChile FrankBrennan Chairperson St George HospitalAustralia SaraDavison Chairperson University of AlbertaCanada Introduction to the Session Including the Prevalence of Symptoms and Available assessment Tools CarlosZuniga Speaker czunigasm2002@yahoo.comDirector of SLANH Kidney Palliative Care CommitteeChile CKM Service Provision: Issues of Resources, Capacity Building, and Advocacy in Low- and Middle-income Countries CarlosZuniga Speaker czunigasm2002@yahoo.comDirector of SLANH Kidney Palliative Care CommitteeChile CKM Service Provision: Issues of Resources, Capacity Building, and Advocacy in High-income Countries JenniferScherer Speaker Jennifer.Scherer@nyulangone.orgNYU School of MedicineUnited States Panel Discussion with Q and A Essential Communication Skills in CKM Including Advance Care Planning JenniferScherer Speaker Jennifer.Scherer@nyulangone.orgNYU School of MedicineUnited States Q and A Transitioning Near the End of Life: Care of the Dying CKM Patient Including Symptomatology in This Period (Shared Presentation: Drs Brennan and Wearne) FrankBrennan Speaker St George HospitalAustralia NicolaWearne Speaker Groote Schuur Hospital / university of Cape TownSouth Africa Q and A Hall C2
2:45 p.m. 4:05 p.m.	Sharing Expertise to Support the Set-up of Renal Registries: The Global Situation and Inspiration from Established Registries in Latin America: Part 2 FergusCaskey Chairperson University of Bristol, UKUnited Kingdom MariaPippias Chairperson University of BristolUnited Kingdom The Uruguayan Renal Registry LeonellaLuzardo Speaker leonellaluzardo@gmail.comNephrology Center Hospital de ClínicasUruguay The Columbian Renal Registry CarlosMejia Speaker mejia.carlos@correoinivalle.edu.coColombia The Costa Rican Renal Registry GuillermoRodriguez Speaker guillermorzmz@gmail.comCosta Rica Panel Discussion with Speakers How To Get Involved In SharE-RR MariaPippias Speaker University of BristolUnited Kingdom Closing and Final Remarks FergusCaskey Speaker University of Bristol, UKUnited Kingdom Sala 1